These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 16143678

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clozapine-Associated Neutropenia and Agranulocytosis.
    Andres E, Mourot-Cottet R.
    J Clin Psychopharmacol; 2017 Dec; 37(6):749-750. PubMed ID: 29040154
    [No Abstract] [Full Text] [Related]

  • 23. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
    Hong X, Wang X.
    Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective.
    Legge SE, Walters JT.
    Pharmacogenomics; 2019 Mar; 20(4):279-290. PubMed ID: 30767710
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
    McKee JR, Wall T, Owensby J.
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Should the clozapine protocol be obeyed?
    Drew L.
    Aust N Z J Psychiatry; 2011 Sep; 45(9):790. PubMed ID: 21668297
    [No Abstract] [Full Text] [Related]

  • 31. Guillain-Barré syndrome after septicemia following clozapine-induced agranulocytosis. A case report.
    Mobascher J, Zielasek J, Schuier FJ, Mobascher A, Grohmann R, Agelink MW, Cordes J.
    Pharmacopsychiatry; 2005 Nov; 38(6):329-30. PubMed ID: 16342008
    [Abstract] [Full Text] [Related]

  • 32. [Chemotherapy during clozapine treatment. Increased risk of agranulocytosis?].
    van Gool AR, van der Velden MT, Oosten AW, van Meerten E, Verhoeven WM, Loonen AJ.
    Tijdschr Psychiatr; 2008 Nov; 50(10):673-8. PubMed ID: 18951346
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A follow-up study of a population of schizophrenic patients treated with clozapine.
    Bourin M, Guitton B, Dailly E, Hery P, Jolliet P.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Nov; 25(8):1481-95. PubMed ID: 11642649
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E, Taylor D.
    CNS Drugs; 2007 Nov; 21(1):25-35. PubMed ID: 17190527
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Increased risk of neutropaenia and agranulocytosis with sodium valproate used adjunctively with clozapine.
    Pantelis C, Adesanya A.
    Aust N Z J Psychiatry; 2001 Aug; 35(4):544-5. PubMed ID: 11531743
    [No Abstract] [Full Text] [Related]

  • 39. Agranulocytosis in a second clozapine trial.
    Gupta S, Noor-Khan N, Frank B.
    Psychiatr Serv; 1998 Aug; 49(8):1094. PubMed ID: 9712222
    [No Abstract] [Full Text] [Related]

  • 40. Re: Late-onset neutropenia with clozapine.
    Duggal HS, Singh I.
    Can J Psychiatry; 2006 Feb; 51(2):125; author reply 125-6. PubMed ID: 16989111
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.